OBJECTIVE: As factors that alter the immune system have been implicated in non-Hodgkin lymphoma (NHL) etiology, it is of interest to explore the association between vaccination and risk of NHL. Results of few epidemiologic studies conducted thus far are inconsistent, and only one has examined the association by histologic subtype. SUBJECTS: A population-based, case-control study of 387 patients with NHL and 535 controls conducted in Nebraska between 1999 and 2002. METHODS: Information on vaccination for tetanus, polio, influenza, smallpox, and tuberculosis, as well as important environmental factors, was collected by telephone interview. Risk was estimated by odds ratios (ORs) and 95% confidence intervals (CIs), adjusting for confounders. RESULTS: We found that NHL risk was inversely associated with ever receiving a polio (OR = 0.59, CI = 0.40-0.87) or smallpox (OR = 0.71, CI = 0.51-0.98) vaccination, and positively associated with influenza vaccination (OR = 1.53, CI = 1.14-2.06). No significant association was found for tetanus or tuberculosis vaccination. The patterns of association were similar between men and women. Analysis by histologic subtypes showed that polio vaccination was associated with a lower risk of follicular (OR = 0.54, CI = 0.31-0.92) and chronic lymphocytic leukemia/small lymphocytic lymphomas (OR = 0.29, CI = 0.12-0.69) and smallpox vaccination was associated with a lower risk of marginal zone lymphoma (OR = 0.41, CI = 0.19-0.88). In contrast, ever receiving an influenza vaccination was associated with a higher risk of follicular (OR = 1.98, CI = 1.23-3.18) and diffuse large B cell lymphomas (OR = 1.88, CI = 1.13-3.12). CONCLUSION: Risk of NHL is inversely associated with polio and smallpox vaccination and positively associated with influenza vaccination. These associations appear to differ by histologic subtype.
OBJECTIVE: As factors that alter the immune system have been implicated in non-Hodgkin lymphoma (NHL) etiology, it is of interest to explore the association between vaccination and risk of NHL. Results of few epidemiologic studies conducted thus far are inconsistent, and only one has examined the association by histologic subtype. SUBJECTS: A population-based, case-control study of 387 patients with NHL and 535 controls conducted in Nebraska between 1999 and 2002. METHODS: Information on vaccination for tetanus, polio, influenza, smallpox, and tuberculosis, as well as important environmental factors, was collected by telephone interview. Risk was estimated by odds ratios (ORs) and 95% confidence intervals (CIs), adjusting for confounders. RESULTS: We found that NHL risk was inversely associated with ever receiving a polio (OR = 0.59, CI = 0.40-0.87) or smallpox (OR = 0.71, CI = 0.51-0.98) vaccination, and positively associated with influenza vaccination (OR = 1.53, CI = 1.14-2.06). No significant association was found for tetanus or tuberculosis vaccination. The patterns of association were similar between men and women. Analysis by histologic subtypes showed that polio vaccination was associated with a lower risk of follicular (OR = 0.54, CI = 0.31-0.92) and chronic lymphocytic leukemia/small lymphocytic lymphomas (OR = 0.29, CI = 0.12-0.69) and smallpox vaccination was associated with a lower risk of marginal zone lymphoma (OR = 0.41, CI = 0.19-0.88). In contrast, ever receiving an influenza vaccination was associated with a higher risk of follicular (OR = 1.98, CI = 1.23-3.18) and diffuse large B cell lymphomas (OR = 1.88, CI = 1.13-3.12). CONCLUSION: Risk of NHL is inversely associated with polio and smallpox vaccination and positively associated with influenza vaccination. These associations appear to differ by histologic subtype.
Authors: Mark T Esser; Rocio D Marchese; Lisa S Kierstead; Lynda G Tussey; Fubao Wang; Narendra Chirmule; Michael W Washabaugh Journal: Vaccine Date: 2003-01-17 Impact factor: 3.641
Authors: Lajos Gergely; Magdolna Aleksza; László Váróczy; Andrea Ponyi; Sándor Sipka; Arpád Illés; Gyula Szegedi Journal: Eur J Haematol Date: 2004-05 Impact factor: 2.997
Authors: Geffen Kleinstern; Melissa C Larson; Stephen M Ansell; Carrie A Thompson; Grzegorz S Nowakowski; Timothy G Call; Dennis P Robinson; Matthew J Maurer; Raphael Mwangi; Andrew L Feldman; Neil E Kay; Anne J Novak; Thomas M Habermann; Susan L Slager; James R Cerhan Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-11-15 Impact factor: 4.090
Authors: Bastiaan A Blok; Kristoffer J Jensen; Peter Aaby; Anders Fomsgaard; Reinout van Crevel; Christine S Benn; Mihai G Netea Journal: Eur J Clin Microbiol Infect Dis Date: 2019-02-05 Impact factor: 5.103
Authors: Andreas Rieckmann; Marie Villumsen; Mette Lundsby Jensen; Henrik Ravn; Zacarias J da Silva; Signe Sørup; Jennifer Lyn Baker; Amabélia Rodrigues; Christine Stabell Benn; Adam E Roth; Peter Aaby Journal: Open Forum Infect Dis Date: 2017-06-20 Impact factor: 3.835